Researcher.Life Logo

Endocrinology, Diabetes and Metabolism : Impact Factor & More

eISSN: 2398-9238pISSN: 2398-9238
JournalOpen Access

Key Metrics

CiteScore
1.6
SJR
Q4Endocrinology, Diabetes and Metabolism
SNIP
0.69
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Endocrinology, Diabetes and Metabolism

Endocrinology, Diabetes and Metabolism Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher WILEY
Language English
Frequency Quarterly
Article Processing ChargesEUR 1650 | GBP 1450 | USD 2200
Publication Time6
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyQuarterly
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 6
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
License typeCC BY
OA statementVisit website
View less

Planning to publish in Endocrinology, Diabetes and Metabolism ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Endocrinology, Diabetes and Metabolism

Glycaemic and Cardiometabolic Outcomes of Empagliflozin Versus Sitagliptin Added to Metformin in T2DM: Insights From a Systematic Review and Meta\u2010Analysis
  • 12 May 2026
  • Endocrinology, Diabetes & Metabolism
The Gastrointestinal Safety of Orforglipron, a GLP\u20101 Receptor Agonist, in Adults With or Without Type 2 Diabetes: A Network Meta\u2010Analysis of Randomized Controlled Trials
  • 11 May 2026
  • Endocrinology, Diabetes & Metabolism
How CGM Use in Adults With Type 2 Diabetes Leads to Glycemic Benefits: The Role of Medication and Behaviour Change.
  • 1 May 2026
  • Endocrinology, diabetes & metabolism
The Effect of Integrated Lifestyle Intervention Incorporating Calorie-Carbohydrate Restriction With or Without Time-Restricted Feeding for Remission of Type 2 Diabetes (DIREM): A Single Blind Randomised Controlled Trial.
  • 1 May 2026
  • Endocrinology, diabetes & metabolism
Gut Dysbiosis as a Shared Mechanism in Obesity and Hypertension: Exploring a Promising Therapeutic Avenue.
  • 1 May 2026
  • Endocrinology, diabetes & metabolism
Poor Glycemic Control in East Africa: Prevalence, Risk Factors and Public Health Implications in Diabetes Management.
  • 1 May 2026
  • Endocrinology, diabetes & metabolism
Glycaemic and Cardiometabolic Outcomes of Empagliflozin Versus Sitagliptin Added to Metformin in T2DM: Insights From a Systematic Review and Meta\u2010Analysis
  • 12 May 2026
  • Endocrinology, Diabetes & Metabolism
The Gastrointestinal Safety of Orforglipron, a GLP\u20101 Receptor Agonist, in Adults With or Without Type 2 Diabetes: A Network Meta\u2010Analysis of Randomized Controlled Trials
  • 11 May 2026
  • Endocrinology, Diabetes & Metabolism
How CGM Use in Adults With Type 2 Diabetes Leads to Glycemic Benefits: The Role of Medication and Behaviour Change.
  • 1 May 2026
  • Endocrinology, diabetes & metabolism
The Effect of Integrated Lifestyle Intervention Incorporating Calorie-Carbohydrate Restriction With or Without Time-Restricted Feeding for Remission of Type 2 Diabetes (DIREM): A Single Blind Randomised Controlled Trial.
  • 1 May 2026
  • Endocrinology, diabetes & metabolism
Gut Dysbiosis as a Shared Mechanism in Obesity and Hypertension: Exploring a Promising Therapeutic Avenue.
  • 1 May 2026
  • Endocrinology, diabetes & metabolism
Poor Glycemic Control in East Africa: Prevalence, Risk Factors and Public Health Implications in Diabetes Management.
  • 1 May 2026
  • Endocrinology, diabetes & metabolism

FAQs on Endocrinology, Diabetes and Metabolism